2012 PROXY

Company

LEXICON PHARMACEUTICALS, INC.

Filed

March 16, 2012

Period of Report

March 16, 2012

Accession Number

0001062822-12-000013

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →